December 8, 2015December 8, 2015

PAH Therapy with Preservative-free Trevyent Shows Promise in Easing Pain

SteadyMed Ltd., a pharmaceutical company focused on developing drugs for the treatment of orphan and high value diseases, has announced positive data from an animal study assessing the clinical effects of its Trevyent® (preservative-free ... Read more

December 29, 2014November 5, 2015

Medtronic Submits Drug Delivery System to FDA to Complement United Therapeutics’ PAH Treatment

News, Pulmonary Hypertension

Medical technology developer Medtronic, Inc. recently completed an application submission to the U.S. Food and Drug Administration (FDA) regarding the pre-market approval of their SynchroMed II implantable drug infusion system, which includes a new catheter design. The ... Read more